Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | KRYS | CYTK | ||
| Company | Acceleron Pharma | Krystal Biotech Inc | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.85 | 375.00 | 86.16 | ||
| High | 179.85 | 375.00 | 86.45 | ||
| Low | 177.06 | 355.55 | 83.59 | ||
| Latest | 178.75 | 365.81 | 84.87 | ||
| Change | -0.93 | -5.43 | -1.20 | ||
| % Change | -0.52% | -1.46% | -1.39% | ||
| Volume | 7,884,200 | 363,500 | 1,768,000 | ||
| 20-Day Average Volume | 1,302,050 | 392,365 | 2,606,985 | ||
| Previous Close | 179.68 | 371.24 | 86.07 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 354.65 | 80.87 | ||
| 20-Day Raw Stochastic | 84.01% | 76.20% | 83.51% | ||
| 20-Day Relative Strength | 70.12 | 63.80 | 62.46 | ||
| Weighted Alpha | +57.78 | +149.15 | +83.71 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | -2.47% since 07/02/26 | -1.87% since 07/02/26 | ||
| Low | 173.17 on 11/16/21 | 355.55 on 07/10/26 | 82.20 on 07/08/26 | ||
| High | 179.94 on 11/17/21 | 382.13 on 07/09/26 | 87.93 on 07/07/26 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | +17.09% since 06/10/26 | +26.54% since 06/10/26 | ||
| Low | 172.25 on 10/20/21 | 312.25 on 06/11/26 | 67.45 on 06/11/26 | ||
| High | 179.94 on 11/17/21 | 382.54 on 06/30/26 | 88.31 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | +41.24% since 04/10/26 | +30.55% since 04/10/26 | ||
| Low | 120.20 on 08/20/21 | 251.97 on 05/04/26 | 58.65 on 04/29/26 | ||
| High | 189.99 on 09/29/21 | 382.54 on 06/30/26 | 88.31 on 06/30/26 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | +39.94% since 01/09/26 | +35.77% since 01/09/26 | ||
| Low | 113.49 on 07/15/21 | 242.00 on 03/31/26 | 58.43 on 03/13/26 | ||
| High | 189.99 on 09/29/21 | 382.54 on 06/30/26 | 88.31 on 06/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 10,944,151 | 10,709,948 | ||
| Shares Outstanding, K | 61,156 | 29,480 | 124,433 | ||
| Annual Sales | 92,520,000 | 389,130,000 | 88,040,000 | ||
| Annual Net Income | -166,030,000 | 204,830,000 | -784,960,000 | ||
| Last Quarter Sales | 34,200,000 | 116,360,000 | 19,360,000 | ||
| Last Quarter Net Income | -70,470,000 | 55,930,000 | -206,030,000 | ||
| 60-Month Beta | 0.13 | 0.50 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 1.83 on 05/04/26 | -1.67 on 05/05/26 | ||
| Earnings Date | 02/24/22 | 08/03/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 50.19 | 0.00 | ||